J Transcat Intervent.2022;30:eA20210042.
Patient with hemophilia and coronary artery disease in the preoperative period of liver transplantation
Priscila Nasser de Carvalho Kroll
, Vinícius Nasser de Carvalho
DOI: 10.31160/JOTCI202230A20210042
ABSTRACT
Hemophilia A and B, although rare, are the most common clotting disorders in humans. With the advent of prophylaxis and improved clotting factor replacement therapy, patients with hemophilia have reached a life expectancy similar to that of the general population, leading to an increase in cardiovascular risk factors and consequently, coronary artery disease. The need for antiplatelet and anticoagulant therapy in these patients further increases the bleeding tendency. Evidence and recommendations for these patients in procedures such as percutaneous coronary intervention are scarce in the literature.
528
